Literature DB >> 3278063

AIDS commentary. Azidothymidine.

M S Hirsch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278063     DOI: 10.1093/infdis/157.3.427

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  THERAPY AND PROPHYLAXIS IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION.

Authors:  Mkk Rao; R M Gupta; V C Ohri
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondii.

Authors:  D M Israelski; C Tom; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.

Authors:  R F Schinazi; D L Cannon; B H Arnold; D Martino-Saltzman
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

4.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.

Authors:  R F Schinazi; J P Sommadossi; V Saalmann; D L Cannon; M Y Xie; G C Hart; G A Smith; E F Hahn
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro.

Authors:  J Bouchard; M C Walker; J M Leclerc; N Lapointe; R Beaulieu; L Thibodeau
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Sentinel surveillance of HIV infection among new inmates and implications for policies of corrections facilities.

Authors:  K K Patel; C Hutchinson; D G Sienko
Journal:  Public Health Rep       Date:  1990 Sep-Oct       Impact factor: 2.792

7.  Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  S Loya; R Tal; Y Kashman; A Hizi
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

8.  Zidovudine and Lamivudine for HIV Infection.

Authors:  Peter L Anderson; Joseph E Rower
Journal:  Clin Med Rev Ther       Date:  2010

9.  Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.

Authors:  Lei Wang; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Acc Chem Res       Date:  2019-12-27       Impact factor: 22.384

Review 10.  Acquired immunodeficiency syndrome: more than a health-related dilemma.

Authors:  M J Severin
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.